Cullinan Therapeutics, Inc. — All Filings
428 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-25-261799 | Nov 3, 2025 | — |
| SCHEDULE 13G/A | — | 0000102909-25-000125 | Oct 30, 2025 | — |
| 4 | — | 0000902664-25-004662 | Oct 30, 2025 | Oct 28, 2025 |
| 4 | — | 0000902664-25-004499 | Oct 21, 2025 | Oct 14, 2025 |
| 4 | — | 0000902664-25-004379 | Oct 10, 2025 | Oct 8, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-004377 | Oct 10, 2025 | — |
| 3 | — | 0000902664-25-004378 | Oct 10, 2025 | Oct 8, 2025 |
| 8-K | 8-K | 0000950170-25-112949 | Sep 4, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-003576 | Aug 14, 2025 | — |
| 3 | 3 | 0000950170-25-106026 | Aug 8, 2025 | Aug 7, 2025 |
| 3 | 3 | 0000950170-25-106027 | Aug 8, 2025 | Aug 7, 2025 |
| 4 | 4 | 0000950170-25-106029 | Aug 8, 2025 | Aug 7, 2025 |
| 4 | 4 | 0000950170-25-106028 | Aug 8, 2025 | Aug 7, 2025 |
| 10-Q | 10-Q | 0000950170-25-104551 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-104547 | Aug 7, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-074813 | Aug 6, 2025 | — |
| 4 | 4 | 0000950170-25-086732 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | 4 | 0000950170-25-086737 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | 4 | 0000950170-25-086726 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | 4 | 0000950170-25-086718 | Jun 16, 2025 | Jun 12, 2025 |
| 4 | 4 | 0000950170-25-086721 | Jun 16, 2025 | Jun 12, 2025 |
| 8-K | 8-K | 0000950170-25-085425 | Jun 12, 2025 | — |
| 8-K | 8-K | 0000950170-25-081601 | Jun 4, 2025 | — |
| 8-K | 8-K | 0000950170-25-066382 | May 8, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-066384 | May 8, 2025 | Mar 31, 2025 |
| ARS | ARS | 0000950170-25-058320 | Apr 25, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0000950170-25-058316 | Apr 25, 2025 | Apr 24, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-058318 | Apr 25, 2025 | — |
| 4 | 4 | 0000950170-25-029201 | Feb 27, 2025 | Feb 25, 2025 |
| 4 | 4 | 0000950170-25-029197 | Feb 27, 2025 | Feb 25, 2025 |
| 8-K | 8-K | 0000950170-25-028343 | Feb 27, 2025 | — |
| 4 | 4 | 0000950170-25-029200 | Feb 27, 2025 | Feb 25, 2025 |
| S-8 | S-8 | 0000950170-25-028351 | Feb 27, 2025 | — |
| 4 | 4 | 0000950170-25-029199 | Feb 27, 2025 | Feb 25, 2025 |
| 10-K | 10-K | 0000950170-25-028346 | Feb 27, 2025 | Dec 31, 2024 |
| 4 | 4 | 0000950170-25-025031 | Feb 21, 2025 | Feb 19, 2025 |
| 4 | 4 | 0000950170-25-025029 | Feb 21, 2025 | Feb 19, 2025 |
| 4 | 4 | 0000950170-25-025032 | Feb 21, 2025 | Feb 19, 2025 |
| 4 | 4 | 0000950170-25-025027 | Feb 21, 2025 | Feb 19, 2025 |
| 4 | 4 | 0000950170-25-025028 | Feb 21, 2025 | Feb 19, 2025 |
| 4 | 4 | 0000950170-25-025030 | Feb 21, 2025 | Feb 19, 2025 |
| 8-K | 8-K | 0000950170-25-010199 | Jan 29, 2025 | Jan 28, 2025 |
| 4 | 4 | 0000950170-25-002946 | Jan 7, 2025 | Jan 6, 2025 |
| 144 | — | 0001950047-25-000127 | Jan 6, 2025 | — |
| 4 | 4 | 0000950170-24-140856 | Dec 27, 2024 | Dec 24, 2024 |
| 4 | 4 | 0000950170-24-139123 | Dec 20, 2024 | Dec 18, 2024 |
| 4 | 4 | 0000950170-24-139124 | Dec 20, 2024 | Dec 18, 2024 |
| 4 | 4 | 0000950170-24-139125 | Dec 20, 2024 | Dec 18, 2024 |
| 4 | 4 | 0000950170-24-136726 | Dec 16, 2024 | Dec 12, 2024 |
| SC 13G/A | SC 13G/A | 0001140361-24-046977 | Nov 14, 2024 | — |